bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Фев. 21, 2024
Abstract
Inflammation
is
a
key
contributor
to
stroke
pathogenesis
and
exacerbates
brain
damage
leading
poor
outcome.
Interleukin-1
(IL-1)
an
important
regulator
of
post-stroke
inflammation,
blocking
its
actions
beneficial
in
pre-clinical
models
safe
the
clinical
setting.
However,
distinct
roles
two
major
IL-1
receptor
type
1
agonists,
IL-1α
IL-1β,
specific
role
ischemic
remain
largely
unknown.
Here
we
show
that
IL-1β
have
different
spatio-temporal
expression
profiles
after
experimental
stroke,
with
early
microglial
(4
h)
delayed
infiltrated
neutrophils
small
subset
(24-72
h).
We
examined
for
first
time
microglial-derived
permanent
transient
through
microglial-specific
tamoxifen-inducible
Cre-loxP-mediated
recombination.
Microglial
deletion
did
not
influence
acute
damage,
cerebral
blood
flow,
expression,
neutrophil
infiltration,
nor
endothelial
activation
stroke.
knock
out
(KO)
mice
showed
reduced
peri-infarct
vessel
density
reactive
astrogliosis
at
14
days
post-stroke,
alongside
long-term
impaired
functional
recovery.
Our
study
identifies
critical
on
neurorepair
recovery
highlighting
importance
targeting
mechanisms
injury
develop
more
effective
therapies.
Journal of Neuroinflammation,
Год журнала:
2025,
Номер
22(1)
Опубликована: Янв. 21, 2025
Abstract
Central
nervous
system
(CNS)
injuries,
such
as
ischemic
stroke
(IS),
intracerebral
hemorrhage
(ICH)
and
traumatic
brain
injury
(TBI),
are
a
significant
global
burden.
The
complex
pathophysiology
of
CNS
is
comprised
primary
secondary
injury.
Inflammatory
incited
by
damage-associated
molecular
patterns
(DAMPs)
which
signal
variety
resident
cells
infiltrating
immune
cells.
Extracellular
cold-inducible
RNA-binding
protein
(eCIRP)
DAMP
acts
through
multiple
non-immune
to
promote
inflammation.
Despite
the
well-established
role
eCIRP
in
systemic
sterile
inflammation,
its
less
elucidated.
Recent
literature
suggests
that
pleiotropic
inflammatory
mediator
also
being
evaluated
clinical
biomarker
indicate
prognosis
injuries.
This
review
provides
broad
overview
injury,
with
focus
on
immune-mediated
neuroinflammation.
We
then
what
known
about
mechanisms
both
non-CNS
cells,
identifying
opportunities
for
further
study.
explore
eCIRP’s
potential
prognostic
marker
severity
outcome.
Next,
we
provide
an
eCIRP-targeting
therapeutics
suggest
strategies
develop
these
agents
ameliorate
Finally,
emphasize
exploring
novel
mechanisms,
aside
from
neuroinflammation,
critical
therapeutic
target
Journal of Biotechnology,
Год журнала:
2024,
Номер
386, С. 10 - 18
Опубликована: Март 20, 2024
Microglia
are
the
resident
macrophages
in
central
nervous
system,
accounting
for
10-15%
of
cell
mass
brain.
Next
to
their
physiological
role
development,
monitoring
neuronal
function
and
maintenance
homeostasis,
microglia
crucial
brain's
immune
defense.
Brain
injury
chronic
neurological
disorders
associated
with
neuroinflammation,
which
activation
is
a
element.
acquire
wide
spectrum
states
diseased
or
injured
brain,
some
neurotoxic.
The
investigation
(patho)physiology
therapeutic
interventions
targeting
neuroinflammation
substantial
challenge.
In
addition
vivo
approaches,
application
vitro
model
systems
has
gained
significant
ground
essential
complement
work.
Primary
cultures
have
proved
be
useful
tool.
offered
opportunity
explore
mechanistic,
molecular
elements
activation,
secretome,
efficacy
treatments
against
neuroinflammation.
As
all
systems,
primary
distinct
strengths
limitations
weighed
when
experiments
designed
data
interpreted.
Here,
we
set
out
provide
succinct
overview
advantages
pitfalls
use
cultures,
instructs
refinement
further
development
this
technique
remain
toolbox
researchers.
Since
there
no
conclusive
therapy
combat
neurotoxicity
linked
acute
brain
neurodegenerative
disorders,
these
research
tools
opportunities.
International Journal of Nanomedicine,
Год журнала:
2024,
Номер
Volume 19, С. 4279 - 4295
Опубликована: Май 1, 2024
Ischemic
stroke,
being
a
prominent
contributor
to
global
disability
and
mortality,
lacks
an
efficacious
therapeutic
approach
in
current
clinical
settings.
Neural
stem
cells
(NSCs)
are
type
of
cell
that
only
found
inside
the
nervous
system.
These
can
differentiate
into
various
kinds
cells,
potentially
regenerating
or
restoring
neural
networks
within
areas
brain
have
been
destroyed.
This
review
begins
by
providing
introduction
existing
approaches
for
ischemic
followed
examination
promise
limits
associated
with
utilization
NSCs
treatment
stroke.
Subsequently,
comprehensive
overview
was
conducted
synthesize
literature
on
underlying
processes
cell-derived
small
extracellular
vesicles
(NSC-sEVs)
transplantation
therapy
context
mechanisms
encompass
neuroprotection,
inflammatory
response
suppression,
endogenous
nerve
vascular
regeneration
facilitation.
Nevertheless,
translation
NSC-sEVs
is
hindered
challenges
such
as
inadequate
targeting
efficacy
insufficient
content
loading.
In
light
these
limitations,
we
compiled
advancements
utilizing
modified
treating
stroke
based
methods
vesicle
modification.
conclusion,
examining
NSC-sEVs-based
anticipated
be
both
fundamental
applied
investigations
about
Brain Research Bulletin,
Год журнала:
2025,
Номер
unknown, С. 111194 - 111194
Опубликована: Янв. 1, 2025
The
arachidonic
acid
metabolic
pathway
is
a
classic
inflammatory
pathway.
12/15-lipoxygenase
(LOX),
member
of
the
lipoxygenase
family
that
metabolizes
acid,
has
been
implicated
in
pathogenesis
numerous
central
nervous
system
(CNS)
diseases.
Ischemic
stroke
devastating
disease
which
occlusion
cerebral
arteries
leads
to
series
pathophysiological
changes
brain
tissue,
triggering
an
cascade
within
results
neuroinflammation.
Prior
research
shown
12/15-LOX
levels
are
elevated
following
stroke.
In
this
review,
we
elaborate
on
key
pathological
mechanisms
unfold
ischemic
stroke,
including
neuroinflammation,
oxidative
stress,
neuronal
apoptosis,
and
blood-brain
barrier
disruption,
present
evidence
demonstrating
inhibition
could
be
used
treat
through
various
avenues.
Furthermore,
list
currently
available
inhibitors
preclinical
or
clinical
applications,
offering
novel
insights
for
early
diagnosis,
prognosis
evaluation,
targeted
therapy
neurological
Journal of Neuroinflammation,
Год журнала:
2025,
Номер
22(1)
Опубликована: Янв. 13, 2025
Lipid
droplets
(LDs),
serving
as
the
convergence
point
of
energy
metabolism
and
multiple
signaling
pathways,
have
garnered
increasing
attention
in
recent
years.
Different
cell
types
within
central
nervous
system
(CNS)
can
regulate
to
generate
or
degrade
LDs
response
diverse
pathological
stimuli.
This
article
provides
a
comprehensive
review
on
composition
CNS,
their
generation
degradation
processes,
interaction
mechanisms
with
mitochondria,
distribution
among
different
types,
roles
played
by
these
cells-particularly
microglia
astrocytes-in
various
prevalent
neurological
disorders.
Additionally,
we
also
emphasize
paradoxical
role
post-cerebral
ischemia
inflammation
explore
potential
underlying
mechanisms,
aiming
identify
novel
therapeutic
targets
for
this
disease.
Journal of Contemporary Medical Practice,
Год журнала:
2025,
Номер
7(1), С. 180 - 185
Опубликована: Янв. 31, 2025
Ischemic
stroke
(IS)
is
a
series
of
pathological
damages
caused
by
the
interruption
local
cerebral
blood
flow.
Its
pathogenesis
extremely
complex,
involving
multiple
signaling
pathways.
Among
them,
Sonic
Hedgehog
(Shh)
pathway
has
become
research
hotspot
in
recent
years.
IS
falls
into
category
"apoplexy".
Apoplexy
also
known
as
stroke.
Traditional
Chinese
medicine
(TCM)
long
history
treating
apoplexy.
The
comprehensive
treatment
methods
TCM
mainly
focus
on
syndrome
differentiation
and
treatment.
According
to
changes
syndromes
different
periods
apoplexy,
carried
out
according
syndrome.
herbal
inexpensive
targets
action.
Based
above
background,
this
study
investigates
how
alleviates
damage
regulating
Shh
pathway,
points
its
shortcomings,
providing
favorable
conditions
for
subsequent
research.
Frontiers in Cellular Neuroscience,
Год журнала:
2025,
Номер
19
Опубликована: Фев. 27, 2025
Chondroitin
sulfate
proteoglycans
(CSPGs),
key
components
of
the
extracellular
matrix
and
glial
scar
that
forms
around
central
nervous
system
(CNS)
injuries,
are
recognized
for
hindering
neuronal
regeneration.
We
previously
demonstrated
potential
pleiotrophin
(PTN)
to
induce
neurite
outgrowth
even
in
presence
inhibitory
CSPGs.
The
effects
PTN
on
microglia
oligodendrocytes
not
well
described.
Here,
we
examined
how
administration
alters
differentiation
oligodendrocyte
precursor
cells
(OPCs)
into
mature
CSPGs
using
vitro
cell
culture
model.
Moreover,
explored
inflammatory
activity
with
without
stimulation
(IFN-γ)
a
CSPG-rich
environment.
data
showed
CSPG
inhibited
OPCs
oligodendrocytes.
induced
dose-dependent
oligodendrocytes,
an
optimal
effect
at
10
nM
PTN.
modified
immunological
response
CSPGs,
reduced
proinflammatory
was
further
by
administration,
contrast
increased
release
metalloproteinases
(MMP
9).
However,
when
IFN-γ-activated
were
treated
PTN,
signaling
stimulated
higher
concentrations
(10
100
nM).
Overall,
our
results
indicate
can
overcome
modulate
inflammation
mediated
from
microglia.
Collectively,
these
findings
demonstrate
effectively
counteract
while
also
modulating
microglial
responses
reduce
increase
MMP-9
release.
Thus,
has
great
improve
remyelination
neuroprotective
strategies
treatment
demyelinating
diseases
or
any
injury.
Exploration of neuroscience,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 11, 2025
Purinergic
signaling,
mediated
by
ATP
and
adenosine
receptors,
plays
a
crucial
role
in
cellular
communication
homeostasis
within
the
central
nervous
system
(CNS),
particularly
regulating
synaptic
activity,
glial
cell
functions,
neuroplasticity.
Glial
cells,
including
astrocytes
microglia,
contribute
to
both
short-term
processes,
such
as
neurotransmission
neuroinflammation,
long-term
remodeling,
tissue
repair,
behavioral
adaptation.
Dysregulation
of
purinergic
signaling
these
cells
has
been
implicated
pathogenesis
various
neurodegenerative
neuropsychiatric
disorders.
This
article
explores
evolving
concept
synapse,
highlighting
active
modulation
emphasizing
significance
function
responses
conditions
injury
neurotoxicity.
Specifically,
it
examines
roles
receptors—such
P2X4,
P2X7,
P2Y1,
P2Y12—in
mediating
key
astrocytic
microglial
phagocytosis,
plasticity,
neuronal
damage.
Furthermore,
discusses
involvement
receptors
neurological
disorders
epilepsy,
Alzheimer’s
disease,
Parkinson’s
multiple
sclerosis,
ischemic
stroke,
Rett
syndrome,
autism
spectrum
disorder,
well
potential
therapeutic
strategies
targeting
mitigate
inflammation,
promote
improve
clinical
outcomes.
Microglial
inflammation
is
a
hallmark
of
ischemic
stroke.
Annexin
A3
(ANXA3)
expressed
in
microglia
and
plays
detrimental
role
However,
the
ANXA3
microglial
after
stroke
unclear.
In
this
study,
an
model
was
established
mice
via
middle
cerebral
artery
occlusion
(MCAO).
The
adeno-associated
virus
shANXA3
(AAV-shANXA3)
injected
into
ipsilateral
cortex
lesion,
infarction
volume,
neurological
score,
neuronal
injury
were
examined.
Moreover,
primary
transfected
with
lentivirus
(LV-shANXA3)
subjected
to
oxygen–glucose
deprivation
(OGD).
Neuron
viability
lactose
dehydrogenase
(LDH)
levels
neurons
cocultured
analyzed.
Additionally,
activation
ANXA3,
p-NF-κB,
NLRP3
downstream
proteins
inflammasome
(cleaved
caspase-1,
N-GSDMD
IL-1β)
expression
measured.
We
found
that
increased
knockdown
reduced
mitigated
deficits,
alleviated
injuries.
ameliorated
p-NF-κB
inhibited
signaling.
Furthermore,
upregulation
resulted
decreased
IκBα
levels,
whereas
downregulation
levels.
Notably,
blocked
neuroprotective
effects
AAV-shANXA3
against
injury.
conclusion,
alleviates
by
inhibiting
NF-κB/NLRP3-mediated
inflammation,
which
indicates
may
be
potential
therapeutic
target
for